Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?

Affiliations

Comment

Pascal Hammel. Nat Clin Pract Oncol. 2007 Aug.

. 2007 Aug;4(8):460-1.

doi: 10.1038/ncponc0884. Epub 2007 Jun 26.

¹ Pôle des Maladies, de l'Appareil Digestif, Hôpital Beaujon, Clichy, France. pascal.hammel@bjn.aphp.fr

No abstract available

Comment on

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Oettle H, et al. JAMA. 2007 Jan 17;297(3):267-77. doi: 10.1001/jama.297.3.267. JAMA. 2007. PMID: 17227978 Clinical Trial.